Treatment with a synthetic antimalarial drug

Psoriasis - Treatment with a synthetic antimalarial drug Factor

Last reviewed for CCPS 10 June 2012.

Investigative Documents

Claimant Report - Treatment with a synthetic antimalarial drug - Psoriasis [CR9238]

Medical Report - Treatment with a synthetic antimalarial drug - Psoriasis [MR9311]

Preliminary questions [34234]

34235

there is some evidence that treatment with a synthetic antimalarial drug may be a factor in the development or worsening of the condition under consideration.

34236 the veteran has been treated with a synthetic antimalarial drug at some time.

34237 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and VEA service for psoriasis.

34238 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and VEA service for the clinical onset of psoriasis.

34242 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and operational service for the clinical onset of psoriasis.

or

34243 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and eligible service for the clinical onset of psoriasis.

or

7334

the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.

7335

the condition under consideration permanently worsened.

34239 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and VEA service for the clinical worsening of psoriasis.

34244 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and operational service for the clinical worsening of psoriasis.

or

34245 — the veteran has established the causal connection between the treatment with a synthetic antimalarial drug and eligible service for the clinical worsening of psoriasis.

Clinical onset and operational service [34242]

34246

as a consequence of operational service, the veteran was treated with a synthetic antimalarial drug.

34250

as a consequence of operational service, the veteran was treated with a synthetic antimalarial drug at the time of the clinical onset of the condition under consideration.

or

34254

the veteran was treated with a synthetic antimalarial drug for treatment of an illness or injury which is identifiable.

34255 for treatment of the identified illness or injury, the veteran was treated with a synthetic antimalarial drug at the time of the clinical onset of the condition under consideration.

34257 — the identified illness or injury for which the veteran was treated with a synthetic antimalarial drug is causally related to operational service.

Clinical onset and eligible service [34243]

34247

as a consequence of eligible service, the veteran was treated with a synthetic antimalarial drug.

34251

as a consequence of eligible service, the veteran was treated with a synthetic antimalarial drug at the time of the clinical onset of the condition under consideration.

or

34254

the veteran was treated with a synthetic antimalarial drug for treatment of an illness or injury which is identifiable.

34255 for treatment of the identified illness or injury, the veteran was treated with a synthetic antimalarial drug at the time of the clinical onset of the condition under consideration.

34258 — the identified illness or injury for which the veteran was treated with a synthetic antimalarial drug is causally related to eligible service.

Clinical worsening and operational service [34244]

34246

as a consequence of operational service, the veteran was treated with a synthetic antimalarial drug.

34252

as a consequence of operational service, the veteran was treated with a synthetic antimalarial drug at the time of the clinical worsening of the condition under consideration.

or

34254

the veteran was treated with a synthetic antimalarial drug for treatment of an illness or injury which is identifiable.

34256 for treatment of the identified illness or injury, the veteran was treated with a synthetic antimalarial drug at the time of the clinical worsening of the condition under consideration.

34257 — the identified illness or injury for which the veteran was treated with a synthetic antimalarial drug is causally related to operational service.

34259

the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury, for which the veteran was treated with a synthetic antimalarial drug, is causally related.

Clinical worsening and eligible service [34245]

34247

as a consequence of eligible service, the veteran was treated with a synthetic antimalarial drug.

34253

as a consequence of eligible service, the veteran was treated with a synthetic antimalarial drug at the time of the clinical worsening of the condition under consideration.

or

34254

the veteran was treated with a synthetic antimalarial drug for treatment of an illness or injury which is identifiable.

34256 for treatment of the identified illness or injury, the veteran was treated with a synthetic antimalarial drug at the time of the clinical worsening of the condition under consideration.

34258 — the identified illness or injury for which the veteran was treated with a synthetic antimalarial drug is causally related to eligible service.

34260

the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury, for which the veteran was treated with a synthetic antimalarial drug, is causally related.